Xilio Therapeutics, Inc. (XLO)

NASDAQ: XLO · IEX Real-Time Price · USD

1.080

+0.040 (3.85%)

At close: May 1, 2024, 4:00 PM

1.090

+0.010 (0.93%)

After-hours: May 1, 2024, 7:00 PM EDT

Xilio Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-76.4	-88.22	-75.8	-55.22	-17.31
Depreciation & Amortization	1.9	1.85	1.5	1.07	0.24
Share-Based Compensation	7.38	8.42	4.96	1.3	0.11
Other Operating Activities	-1.5	2.23	-11.41	16.77	-0.88
Operating Cash Flow	-68.62	-75.72	-80.75	-36.09	-17.84
Capital Expenditures	-0.49	-1.87	-1.1	-2.19	-0.72
Investing Cash Flow	-0.49	-1.87	-1.1	-2.19	-0.72
Share Issuance / Repurchase	0.2	0.02	116.64	0.16	0
Debt Issued / Paid	-6.75	-0.09	-0.11	-0.1	9.95
Other Financing Activities	-	-	144.14	9.97	50.07
Financing Cash Flow	-6.55	-0.07	260.67	10.03	60.02
Net Cash Flow	-75.66	-77.66	178.82	-28.25	41.46
Free Cash Flow	-69.11	-77.59	-81.85	-38.28	-18.56
Free Cash Flow Per Share	-2.51	-2.83	-14.60	-73.08	-4.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).